Three-Component Zn(OAc)2-Catalyzed one pot synthesis of mono and disubstituted Pyrimidine Derivatives.
DOI:
https://doi.org/10.46243/jst.2024.v9.i4.pp1-7Keywords:
.Abstract
The Zn(OAc)2-catalyzed three-component coupling reaction using triethyl orthoformate (3 eq.), and ammonium acetate (2 eq.), to synthesis mono & disubstituted pyrimidine derivatives in single step. This method is successfully applied to the efficient synthesis of mono- and disubstituted pyrimidine derivatives, using methyl ketone derivatives by using biodegradable,ecofriendly polychem@36 as solvent in ultrasound condition at 800C giving good yield upto 80-90% .The reaction is completed in short period of time i.e. 1-3 hrs as compared to other reaction.
References
Waterson, A. G.; Stevens, K. L.; Reno, M. J.; Zhang,. Med. Chem. Lett. 2006, 16, 2419
Dickinson, R. P.; Bell, A. S.; Hitchcock, C. A.; Narayanaswami, S.; Ray, S. J.; Richardson, K.; Troke, P. F. Bioorg. Med. Chem. Lett. 1996, 6, 2031
Brodfuehrer, P. R.; Chen, B.-C.; Sattelberg, T. R., Sr.; Smith, P. R.; Reddy, J. P.; Stark, D. R.; Quinlan, S. L.; Reid, J. G.; Thottathil, J. K.; Wang, S. J. Org. Chem. 1997, 62, 9192
For selected papers, see: (a) Zhang, Y.-M.; Razler, T.; Jackson, P. F. Tetrahedron Lett. 2002, 43, 8235
(a) Hill, M. D.; Movassaghi, M. Chem.-Eur. J. 2008, 14, 6836. (b) D’Souza, D. M.; Mueller, T. J. J. Chem
(a) Movassaghi, M.; Hill, M. D. J. Am. Chem. Soc. 2006, 128, 14254. (b) Karpov, A. S.; Merkul, E.; Rominger, F.; Mueller, T. J. J. Angew. Chem., Int. Ed. 2005
For selected papers on the Bredereck-type synthesis of 4,5- disubstituted pyrimidines, see: (a) Bredereck, H.; Gompper, R.; Morlock, G. Chem. Ber. 1957, 90, 942
Pinner, A. Ber. 1893, 26, 2122. (b) Baran, P. S.; Shenvi, R. A.; Nguyen, S. A. Heterocycles 2006, 70, 581
Nishiwaki, N.; Ariga, M. Top. Heterocycl. Chem. 2007, 8, 43
Sard, H.; Gonzalez, M. D.; Mahadevan, A.; McKew, J. J. Org. Chem. 2000, 65, 9261
Brummelte S., MC Glanaghy E Neuroscience. 2017;342:212–231. doi: 10.1016/j. neuroscience.2016.02.037
Amato D. Behav. Brain Res. 2015;277:125–135. doi: 10.1016/j.bbr.2014.07.025
Meltzer H.Y., Li Z., Kaneda Y., Ichikawa Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2003;27:1159–1172. doi: 10.1016/j. pnpbp.2003.09.010
Hoyer D., Clarke D.E., Fozard J.R., Hartig P.R., Martin G.R.,Pharmacol. Rev. 1994;46:157–203
McCorvy J.D., Roth B.L. Pharmacol. Ther. 2015;150:129–142. doi: 10.1016/j. pharmthera.2015.01.009
Chou-Green J.M., Holscher T.D., Dallman M.F., Akana Physiol. Behav. 2003;78:641–649. doi: 10.1016/S0031-9384(03)00047-7
Lee M.A., Jayathilake K., Sim M.Y., Meltzer H.Y. Psychiatry Res. 2015;226:308–315. doi: 10.1016/j.psychres.2015.01.007
Chagraoui A., Thibaut F., Skiba M., Thuillez C., Bourin Prog. Neuro Psychopharmacol. Biol. Psychiatry. 2016;66:120–135. doi: 10.1016/j. pnpbp.2015.12.006
Barnes N.M., Sharp T.A. Review of central 5-HT receptors and their function. Neuropharmacology. 1999;38:1083–1152. doi: 10.1016/S0028-3908(99)00010-6
Berg K.A., Stout B.D., Cropper J.D., Maayani S., Clarke Mol. Pharmacol. 1999;55:863–872
Thomsen W.J., Grottick A.J., Menzaghi F., Reyes-Saldana H., Espitia S., Yuskin D., Whelan K., Martin M., Morgan M., Chen W., JPET. 2008;325:577–587. doi: 10.1124/ jpet.107.133348




